159 related articles for article (PubMed ID: 29776637)
1. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
Kiavash K; Bluth MH; Thompson AD
Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
[TBL] [Abstract][Full Text] [Related]
2. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
4. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
5. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
March J; Hand M; Truong A; Grossman D
J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
[TBL] [Abstract][Full Text] [Related]
6. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
7. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence In Situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal.
Ferrara G; De Vanna AC
Am J Dermatopathol; 2016 Apr; 38(4):253-69. PubMed ID: 26999337
[TBL] [Abstract][Full Text] [Related]
9. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
10. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
11. Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
Mesbah Ardakani N; Thomas C; Robinson C; Mina K; Harvey NT; Amanuel B; Wood BA
Pathology; 2017 Apr; 49(3):285-291. PubMed ID: 28274670
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
13. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
14. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of Spitzoid Neoplasms Impacting Patient Management.
Hillen LM; Van den Oord J; Geybels MS; Becker JC; Zur Hausen A; Winnepenninckx V
Front Med (Lausanne); 2018; 5():344. PubMed ID: 30619857
[TBL] [Abstract][Full Text] [Related]
16. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
[TBL] [Abstract][Full Text] [Related]
17. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.
Miedema J; Andea AA
Mod Pathol; 2020 Jul; 33(7):1318-1330. PubMed ID: 32066861
[TBL] [Abstract][Full Text] [Related]
18. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
19. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
20. Current applications of molecular genetic technologies to the diagnosis and treatment of cutaneous melanocytic neoplasms.
Zulfiqar M; Thompson AD
Clin Lab Med; 2013 Dec; 33(4):881-90. PubMed ID: 24267193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
